Phreesia (NYSE:PHR) Stock Price Down 2.4% – Time to Sell?

Phreesia, Inc. (NYSE:PHR)’s stock price traded down 2.4% during trading on Friday . The stock traded as low as $24.62 and last traded at $24.84. 107,533 shares were traded during trading, a decline of 74% from the average session volume of 418,204 shares. The stock had previously closed at $25.45.

Analyst Upgrades and Downgrades

PHR has been the topic of a number of recent analyst reports. KeyCorp boosted their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Citigroup raised their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Robert W. Baird cut their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Finally, Truist Financial boosted their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia has an average rating of “Buy” and an average target price of $31.23.

Phreesia Stock Down 1.1 %

The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a 50 day moving average price of $27.32 and a 200-day moving average price of $24.00. The stock has a market capitalization of $1.46 billion, a P/E ratio of -17.13 and a beta of 1.03.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period last year, the company earned ($0.58) EPS. As a group, research analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Transactions at Phreesia

In other news, SVP Amy Beth Vanduyn sold 1,311 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $34,885.71. Following the sale, the senior vice president now owns 115,633 shares of the company’s stock, valued at approximately $3,076,994.13. This represents a 1.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 3,495 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total value of $86,955.60. Following the completion of the sale, the general counsel now owns 116,296 shares of the company’s stock, valued at $2,893,444.48. The trade was a 2.92 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 163,322 shares of company stock valued at $4,631,915 over the last quarter. 5.80% of the stock is currently owned by company insiders.

Institutional Trading of Phreesia

Several hedge funds and other institutional investors have recently bought and sold shares of PHR. Johnson Financial Group Inc. boosted its position in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares in the last quarter. R Squared Ltd purchased a new position in Phreesia in the fourth quarter worth $30,000. BankPlus Trust Department acquired a new position in shares of Phreesia during the fourth quarter worth $34,000. Quarry LP boosted its position in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after purchasing an additional 1,923 shares in the last quarter. Finally, Venturi Wealth Management LLC purchased a new stake in Phreesia in the fourth quarter valued at about $76,000. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.